Rituximab (MabThera®) for aggressive non-Hodgkin's lymphoma

Source:
NIHR Journals Library - Health Technology Assessment
Publisher:
NIHR Journals Library – Health Technology Assessment
Publication date:
01 September 2004

Abstract

(2004) Rituximab (MabThera®) for aggressive non-Hodgkin's lymphoma. NIHR Journals Library - Health Technology Assessment: Health Technology Assessment (HTA) publishes research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. Find out more about the HTA journal at https://www.journalslibrary.nihr.ac.uk/hta/#/.